|
Gene: GATB |
Gene summary for GATB |
Gene summary. |
Gene information | Species | Human | Gene symbol | GATB | Gene ID | 5188 |
Gene name | glutamyl-tRNA amidotransferase subunit B | |
Gene Alias | COXPD41 | |
Cytomap | 4q31.3 | |
Gene Type | protein-coding | GO ID | GO:0006082 | UniProtAcc | O75879 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5188 | GATB | LZE24T | Human | Esophagus | ESCC | 2.49e-04 | 1.16e-01 | 0.0596 |
5188 | GATB | P2T-E | Human | Esophagus | ESCC | 9.19e-10 | 2.71e-01 | 0.1177 |
5188 | GATB | P4T-E | Human | Esophagus | ESCC | 1.27e-04 | 1.30e-01 | 0.1323 |
5188 | GATB | P5T-E | Human | Esophagus | ESCC | 1.70e-03 | 1.16e-01 | 0.1327 |
5188 | GATB | P8T-E | Human | Esophagus | ESCC | 4.49e-03 | 9.05e-02 | 0.0889 |
5188 | GATB | P9T-E | Human | Esophagus | ESCC | 9.93e-05 | 9.49e-02 | 0.1131 |
5188 | GATB | P10T-E | Human | Esophagus | ESCC | 4.19e-08 | 7.09e-02 | 0.116 |
5188 | GATB | P11T-E | Human | Esophagus | ESCC | 3.24e-02 | 1.66e-01 | 0.1426 |
5188 | GATB | P12T-E | Human | Esophagus | ESCC | 6.36e-18 | 3.68e-01 | 0.1122 |
5188 | GATB | P15T-E | Human | Esophagus | ESCC | 4.05e-07 | 1.42e-01 | 0.1149 |
5188 | GATB | P16T-E | Human | Esophagus | ESCC | 8.25e-12 | 2.81e-01 | 0.1153 |
5188 | GATB | P20T-E | Human | Esophagus | ESCC | 1.42e-09 | 1.07e-01 | 0.1124 |
5188 | GATB | P21T-E | Human | Esophagus | ESCC | 4.30e-07 | 1.90e-01 | 0.1617 |
5188 | GATB | P22T-E | Human | Esophagus | ESCC | 4.65e-10 | 2.30e-01 | 0.1236 |
5188 | GATB | P24T-E | Human | Esophagus | ESCC | 1.27e-04 | 1.68e-01 | 0.1287 |
5188 | GATB | P26T-E | Human | Esophagus | ESCC | 4.97e-09 | 2.03e-01 | 0.1276 |
5188 | GATB | P27T-E | Human | Esophagus | ESCC | 1.09e-04 | 1.74e-01 | 0.1055 |
5188 | GATB | P30T-E | Human | Esophagus | ESCC | 5.12e-07 | 2.02e-01 | 0.137 |
5188 | GATB | P31T-E | Human | Esophagus | ESCC | 3.01e-10 | 1.88e-01 | 0.1251 |
5188 | GATB | P32T-E | Human | Esophagus | ESCC | 6.81e-18 | 3.81e-01 | 0.1666 |
Page: 1 2 3 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003466012 | Esophagus | ESCC | ncRNA metabolic process | 346/8552 | 485/18723 | 4.35e-31 | 2.51e-28 | 346 |
GO:014005313 | Esophagus | ESCC | mitochondrial gene expression | 93/8552 | 108/18723 | 1.96e-18 | 2.03e-16 | 93 |
GO:003254314 | Esophagus | ESCC | mitochondrial translation | 68/8552 | 76/18723 | 1.02e-15 | 6.86e-14 | 68 |
GO:00063992 | Esophagus | ESCC | tRNA metabolic process | 122/8552 | 179/18723 | 9.03e-10 | 2.19e-08 | 122 |
GO:00346605 | Oral cavity | OSCC | ncRNA metabolic process | 296/7305 | 485/18723 | 2.94e-23 | 6.65e-21 | 296 |
GO:01400533 | Oral cavity | OSCC | mitochondrial gene expression | 78/7305 | 108/18723 | 2.37e-12 | 9.86e-11 | 78 |
GO:00325434 | Oral cavity | OSCC | mitochondrial translation | 59/7305 | 76/18723 | 7.21e-12 | 2.70e-10 | 59 |
GO:00063991 | Oral cavity | OSCC | tRNA metabolic process | 101/7305 | 179/18723 | 1.65e-06 | 2.15e-05 | 101 |
GO:003466011 | Oral cavity | LP | ncRNA metabolic process | 205/4623 | 485/18723 | 6.46e-18 | 1.09e-15 | 205 |
GO:003254313 | Oral cavity | LP | mitochondrial translation | 43/4623 | 76/18723 | 2.85e-09 | 1.26e-07 | 43 |
GO:014005312 | Oral cavity | LP | mitochondrial gene expression | 53/4623 | 108/18723 | 3.54e-08 | 1.27e-06 | 53 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GATB | SNV | Missense_Mutation | rs766660548 | c.1051N>A | p.Ala351Thr | p.A351T | O75879 | protein_coding | tolerated(0.63) | benign(0.003) | TCGA-4R-AA8I-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
GATB | SNV | Missense_Mutation | novel | c.1236N>G | p.Ile412Met | p.I412M | O75879 | protein_coding | tolerated(0.55) | benign(0.003) | TCGA-DD-AADA-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GATB | SNV | Missense_Mutation | rs749000969 | c.673N>A | p.Asp225Asn | p.D225N | O75879 | protein_coding | deleterious(0.01) | possibly_damaging(0.845) | TCGA-DD-AAVR-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
GATB | SNV | Missense_Mutation | novel | c.1472N>T | p.Gln491Leu | p.Q491L | O75879 | protein_coding | tolerated(0.08) | benign(0.038) | TCGA-G3-A3CG-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Targeted Molecular therapy | sorafenib | SD |
GATB | SNV | Missense_Mutation | novel | c.774N>T | p.Leu258Phe | p.L258F | O75879 | protein_coding | deleterious(0.04) | probably_damaging(0.964) | TCGA-05-4396-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
GATB | SNV | Missense_Mutation | novel | c.336C>G | p.Asn112Lys | p.N112K | O75879 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-05-4397-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
GATB | SNV | Missense_Mutation | novel | c.119N>C | p.Arg40Thr | p.R40T | O75879 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.987) | TCGA-44-7662-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
GATB | SNV | Missense_Mutation | novel | c.1200N>A | p.Asn400Lys | p.N400K | O75879 | protein_coding | deleterious(0) | possibly_damaging(0.856) | TCGA-55-8206-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
GATB | insertion | Frame_Shift_Ins | novel | c.1529_1530insA | p.Ala511GlyfsTer19 | p.A511Gfs*19 | O75879 | protein_coding | TCGA-CR-7365-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | unknown | SD | ||
GATB | SNV | Missense_Mutation | rs377007052 | c.1603C>T | p.Arg535Trp | p.R535W | O75879 | protein_coding | tolerated(0.06) | possibly_damaging(0.828) | TCGA-G9-6347-01 | Prostate | prostate adenocarcinoma | Male | <65 | 6 | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |